Designing molecules for a target
The models reason about biological structure and function to propose new molecular designs. The company’s latest work focuses on improving antibody binding and the success of designs tested in the laboratory.
Expanding research and deployment
The San Francisco team will expand compute, data and model research, develop the software platform and bring it to more scientists. The goal is to make candidate design a more predictable step in pre-clinical discovery.
Where the funding goes
- Compute and research data
- Model research
- Product development
- Scientific deployments